SCHEMBL2228657

SCHEMBL2228657

CCCCC(N)(CCCC)CCCC.CCCCOP(=O)(O)OCCCC

nearest known ligand 0.50

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.50
CYP3A4 P08684 1/20 0.47
LPAR3 Q9UBY5 4/20 0.46
LPAR1 Q92633 2/20 0.46
LPAR2 Q9HBW0 2/20 0.46
SMPD1 P17405 4/20 0.43
S1PR1 P21453 1/20 0.41
P2RY10 O00398 4/20 0.39
GPR34 Q9UPC5 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2230503 0.87 LPAR3 (0.52) FDPSCYP3A4LPAR3LPAR1LPAR2
Diethyl Hydrogen Phosphate SCHEMBL855448 0.87 FDPS (0.52) FDPSLPAR3LPAR1LPAR2SMPD1
SCHEMBL672799 0.86 CYP3A4 (0.61) CYP3A4LPAR3LPAR1LPAR2P2RY10
Chloromethane SCHEMBL11360800 0.84 CYP3A4 (0.58) FDPSCYP3A4LPAR3LPAR1LPAR2
SCHEMBL29177519 0.84 CYP3A4 (0.64) CYP3A4LPAR3LPAR1LPAR2P2RY10
SCHEMBL26559 0.84 CYP3A4 (0.64) CYP3A4LPAR3LPAR1LPAR2P2RY10
SCHEMBL15389152 0.84 CYP3A4 (0.64) CYP3A4LPAR3LPAR1LPAR2P2RY10
Diethyl Hydrogen Phosphate SCHEMBL625868 0.84 FDPS (0.52) FDPSSMPD1
Diethyl Hydrogen Phosphate SCHEMBL625440 0.84 FDPS (0.48) FDPSCYP3A4LPAR3LPAR1LPAR2
SCHEMBL945567 0.82 CYP3A4 (0.61) CYP3A4LPAR3LPAR1LPAR2P2RY10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3275039-B1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF CORP (US) 2025-08-27 EP claimed
WO-2024081696-A2 COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME PHASE CHANGE ENERGY SOLUTIONS, INC. (US) 2024-04-18 WO claimed
CN-107710462-B Electrochemical hydrogen storage electrode and battery 巴斯夫公司 2022-08-02 CN claimed
CN-107004912-B Electrolyte and metal hydride battery 巴斯夫公司 2021-07-30 CN claimed
WO-2021127642-A1 SELECTIVE VALORIZATION OF BIOMASS SUGARS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-06-24 WO claimed
EP-3292578-B1 ELECTROCHEMICAL HYDROGEN STORAGE ELECTRODES AND CELLS BASF CORP (US) 2021-02-24 EP claimed
US-10587012-B2 Electrolyte compositions comprising ionic liquids and metal hydride batteries comprising same BASF CORPORATION (US) 2020-03-10 US claimed
US-10243240-B2 Electrolytes and metal hydride batteries BASF CORPORATION (US) 2019-03-26 US claimed
EP-3292578-A1 ELECTROCHEMICAL HYDROGEN STORAGE ELECTRODES AND CELLS BASF Corporation (US) 2018-03-14 EP claimed
EP-3275039-A1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF Corporation (US) 2018-01-31 EP claimed
EP-3218955-A1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF Corporation (US) 2017-09-20 EP claimed
US-20160365228-A1 COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE LAM RESEARCH CORPORATION 2016-12-15 US claimed
US-20160329560-A1 Electrochemical Hydrogen Storage Electrodes and Cells BASF CORPORATION (US) 2016-11-10 US claimed
US-20160285130-A1 Electrolytes and Metal Hydride Batteries U.S. DEPARTMENT OF ENERGY 2016-09-29 US claimed
US-9449797-B2 Component of a plasma processing apparatus having a protective in situ formed layer on a plasma exposed surface LAM RESEARCH CORPORATION (US) 2016-09-20 US claimed
US-20160141727-A1 Electrolytes and Metal Hydride Batteries BASF CORPORATION 2016-05-19 US claimed
US-20160141726-A1 Electrolytes and Metal Hydride Batteries BASF CORPORATION 2016-05-19 US claimed
US-20140335698-A1 COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE LAM RESEARCH CORPORATION (US) 2014-11-13 US claimed
US-20260132324-A1 COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME PHASE CHANGE ENERGY SOLUTIONS, INC. (US) 2026-05-14 US disclosed
WO-2011091131-A2 ESLICARBAZEPINE ACETATE AND ITS POLYMORPHS DR. REDDY'S LABORATORIES LTD. (IN) 2011-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132324-A1 COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME GK, CETP, ICOSLG FDPS 1094/4885CYP3A4 1939/4885LPAR3 3039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.